Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...

However, because our bodies develop antibodies for other reasons, the results of an ANA test by itself don’t determine a diagnosis of scleroderma. It is important to remember that scleroderma is a ...

Antibody titres against measles, mumps and rubella were measured using ELISA and against varicella using an immunofluorescence assay. Main outcome measures To demonstrate non-inferiority of the 2 ...

Of these, 10 had anti-AQP4 antibody-positive NMOSD, 5 had anti-MOG antibody-positive NMOSD, and 30 were double seronegative. The patients’ median best corrected visual acuity was 1.7 at onset. The ...

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its ...

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ® Published. Jun 5, 2025 11:45am EDT.

DFA: Direct fluorescent antibody; VZV: Varicella zoster virus. References. Authors and Disclosures. ... The clinical significance of positive molecular results may vary in the individual patient.

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its ...

Positive results for modified version. In the June 2025 issue of The Lancet HIV, a team of researchers reported the results of an open-label phase 1 trial of PGDM1400LS that was the first to test the ...

The second dose of MMRV elicited slight to moderate increases in measles, mumps and rubella antibody titers and a substantial increase in varicella antibody titer (from 13.0 to 588.1 glycoprotein ...